Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.61 |
| ▸ | ALB | P02768 | 1/20 | 0.50 |
| ▸ | G6PD | P11413 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | CDC25B | P30305 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 3/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31227767 | 1.00 | MMP2 (0.61) | MMP2ALBG6PDCASP7CASP6 | |
| Hydrochloric Acid SCHEMBL28822564 | 0.98 | MMP2 (0.59) | MMP2ALBG6PDCASP7CASP6 | |
| Trifluoroacetic Acid SCHEMBL3783854 | 0.91 | MMP2 (0.52) | MMP2ALBG6PDCASP7CASP6 | |
| Deanol SCHEMBL8783637 | 0.85 | MMP2 (0.46) | MMP2ALBG6PDCASP7CASP6 | |
| SCHEMBL336107 | 0.84 | ALDH1A1 (0.60) | MMP2ALBG6PDCASP7CASP6 | |
| SCHEMBL31413038 | 0.83 | MMP2 (0.45) | MMP2ALBG6PDCASP7CASP6 | |
| SCHEMBL27651120 | 0.83 | MMP2 (0.45) | MMP2CASP7KEAP1ALDH1A1ALOX15 | |
| SCHEMBL30623038 | 0.83 | MMP2 (0.45) | MMP2CASP7KEAP1ALDH1A1ALOX15 | |
| SCHEMBL21707970 | 0.81 | ALDH1A1 (0.52) | MMP2ALBG6PDCASP7CASP6 | |
| SCHEMBL13862137 | 0.81 | MMP2 (0.44) | MMP2ALDH1A1MAPTGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119490423-A | Method for preparing 2-fluoro-3-aminobenzoic acid and ester compound thereof | 沈阳中化农药化工研发有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119490422-A | Synthesis method of 2-fluoro-3-aminobenzoic acid and ester compound thereof | 沈阳中化农药化工研发有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119490421-A | Method for synthesizing 2-fluoro-3-aminobenzoic acid and ester compound thereof | 沈阳中化农药化工研发有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119490424-A | Preparation method of 2-fluoro-3-aminobenzoic acid and ester compound | 沈阳中化农药化工研发有限公司 | 2025-02-21 | — | — | CN | claimed |
| WO-2025036387-A1 | PREPARATION METHOD FOR 2-FLUORO-3-AMINOBENZOIC ACID AND ESTER COMPOUNDS | 沈阳中化农药化工研发有限公司 | 2025-02-20 | — | — | WO | claimed |
| WO-2025036384-A1 | METHOD FOR PREPARING 2-CHLORO-3-AMINOBENZOIC ACID AND ESTER COMPOUND THEREOF | 沈阳中化农药化工研发有限公司 | 2025-02-20 | — | — | WO | claimed |
| CN-114920661-B | Synthesis method of 2-fluoro-3-aminobenzoic acid | 浙江沙星科技股份有限公司 | 2024-01-02 | — | — | CN | claimed |
| CN-115850103-B | Preparation method of 3-amino-2-fluorobenzoic acid methyl ester | 北京颖泰嘉和生物科技股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-115850103-A | Preparation method of 3-amino-2-fluorobenzoic acid methyl ester | 北京颖泰嘉和生物科技股份有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-114920661-A | Synthetic method of 2-fluoro-3-aminobenzoic acid | 浙江沙星科技有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-121574054-B | Preparation method of 2-fluoro-3-nitrobenzoic acid | 济南国鼎医药科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-121574054-A | Preparation method of 2-fluoro-3-nitrobenzoic acid | 济南国鼎医药科技有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-12427146-B2 | C-terminal SRC kinase inhibitors | InventisBio Co., Ltd. (CN) | 2025-09-30 | — | — | US | disclosed |
| US-12280023-B2 | Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia | ATROGI AB (SE) | 2025-04-22 | — | — | US | disclosed |
| CN-119552089-A | Preparation method of 3-amino-2-fluorobenzoyl chloride and derivatives thereof | 帕潘纳(北京)科技有限公司 | 2025-03-04 | — | — | CN | disclosed |
| US-20070082912-A1 | Pyrrole compounds for the treatment of prostaglandine mediated diseases | GLAXO GROUP LIMITED (GB) | 2007-04-12 | — | — | US | disclosed |
| EP-0831845-B1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS IN (US) | 2004-09-08 | — | — | EP | disclosed |
| EP-0831845-A4 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS IN (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0831845-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | Elizanor Biopharmaceuticals, Inc. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040156-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427146-B2 | C-terminal SRC kinase inhibitors | CSK, SRC, CSNK1G2 | MMP2 2666/4885ALB 4762/4885G6PD 3330/4885 |
| US-20070082912-A1 | Pyrrole compounds for the treatment of prostaglandine mediated diseases | PTGER1, PTGDR, PTGIR | MMP2 3999/4885ALB 4172/4885G6PD 2022/4885 |
| US-12280023-B2 | Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia | GPR119, SLC5A2, SLC5A1 | MMP2 2417/4885ALB 500/4885G6PD 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.